Company News
BioRestorative Halts ExoCR, BioX Shipments
BioRestorative Therapies (NASDAQ:BRTX) halted all orders and shipments of its ExoCR and BioX biocosmeceutical lines effective August 7 pending a regulatory review.
With a $5.61 million market cap, the
